Alexander Pearlman, Ph.D.
My research is dedicated to studying the biology of metastatic cancer through the lens of somatic tumor genomics. The goal is to utilize genomic insights of metastasis biology for building a translational research program that incorporate cellular and animal models to guide combinatorial reformulations of currently FDA approved and off patent cancer therapies and off label utilization of therapies not intended to treat cancer. These functional studies will be integrated with each patient's specific genomic profile and paralyzed into actionable treatment decisions and therapies. My goal is to push the envelope for personalized medical solutions-improving patient quality of life, reducing cancer mortality rates and reducing health care costs.
Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.